Goldman Sachs
IRON icon

Goldman Sachs’s Disc Medicine IRON Stock Holding History

Goldman Sachs’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.12M Sell
97,383
-542,459
-85% -$37.3M ﹤0.01% 3567
2026
Q1 		$40.9M Sell
639,842
-114,353
-15% -$7.94M ﹤0.01% 1735
2025
Q4 		$59.9M Buy
754,195
+225,114
+43% +$19M 0.01% 1357
2025
Q3 		$35M Buy
529,081
+303,225
+134% +$18M ﹤0.01% 1729
2025
Q2 		$12M Buy
225,856
+95,105
+73% +$4.47M ﹤0.01% 2603
2025
Q1 		$6.49M Sell
130,751
-41,059
-24% -$2.28M ﹤0.01% 3104
2024
Q4 		$10.9M Buy
171,810
+244
+0.1% +$14.1K ﹤0.01% 2715
2024
Q3 		$8.43M Buy
171,566
+117,319
+216% +$5.51M ﹤0.01% 2890
2024
Q2 		$2.44M Sell
54,247
-14,156
-21% -$481K ﹤0.01% 3778
2024
Q1 		$4.26M Buy
68,403
+6,228
+10% +$404K ﹤0.01% 3241
2023
Q4 		$3.59M Buy
62,175
+34,821
+127% +$1.78M ﹤0.01% 3442
2023
Q3 		$1.29M Buy
+27,354
New +$1.37M ﹤0.01% 4092
2023
Q2 		– Sell
-21,674
Closed -$459K – 5908
2023
Q1 		$459K Buy
+21,674
New +$483K ﹤0.01% 4864
2022
Q4 		– Sell
-650
Closed -$32K – 6131
2022
Q3 		$32K Sell
650
-571
-47% -$26.9K ﹤0.01% 5850
2022
Q2 		$62K Buy
1,221
+543
+80% +$24K ﹤0.01% 5980
2022
Q1 		$28K Sell
678
-1,748
-72% -$91.7K ﹤0.01% 6366
2021
Q4 		$212K Buy
2,426
+1,929
+388% +$189K ﹤0.01% 5871
2021
Q3 		$60K Buy
497
+61
+14% +$8.34K ﹤0.01% 6007
2021
Q2 		$85K Sell
436
-879
-67% -$289K ﹤0.01% 5978
2021
Q1 		$535K Buy
+1,315
New +$587K ﹤0.01% 5065

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs's IRON Position: Q2 2026 in Review

Goldman Sachs reduced its Disc Medicine (IRON) stake by 85% in Q2 2026, selling an estimated $37.3M and leaving 97,383 shares worth $7.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3567.

Goldman Sachs first reported a position in IRON in Q1 2021 and has held it in 20 quarters since. The position peaked at $59.9M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Goldman Sachs held 97,383 shares of Disc Medicine worth $7.12M as of Q2 2026.
  • Goldman Sachs sold 542,459 Disc Medicine shares in Q2 2026, an estimated $37.3M.
  • Disc Medicine made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3567 holding.
  • Goldman Sachs first reported a position in Disc Medicine in Q1 2021 and has held it in 20 quarters since.
  • Goldman Sachs's Disc Medicine position peaked at $59.9M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.